Monaco Asset Management SAM

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1803593 Monaco, O9

Position in MRVI

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$13,921,602

+$4,240,116 QoQ

Shares Held

2,231,026

-34.8% QoQ

Ownership

0.859%

of shares outstanding

% of Portfolio

5.35%

of 13F equity value

Holder Rank

#16

of 176 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Monaco Asset Management SAM holds $49,930,003 across 9 Biotechnology names. MRVI ranks #1 (27.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRVI	Maravai Lifesciences Holdings, Inc. This page	2,231,026	$13,921,602
2	BMRN	Biomarin Pharmaceutical Inc	184,937	$10,582,095
3	RCKT	Rocket Pharmaceuticals, Inc.	2,480,468	$8,483,200
4	NKTX	Nkarta, Inc.	2,373,400	$6,716,722
5	NVAX	Novavax Inc	577,464	$5,439,710
6	PLRX	Pliant Therapeutics, Inc.	1,938,747	$2,210,171
7	VNDA	Vanda Pharmaceuticals Inc.	221,286	$1,354,270
8	LKFT	Lakefront Biotherapeutics NV	25,600	$767,488

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,921,602	2,231,026	-34.8%	Shares	Sole	2026-08-07
2026-03-31	$9,681,486	3,421,020	-1.1%	Shares	Sole	2026-05-11
2025-12-31	$11,245,617	3,460,190	-5.4%	Shares	Sole	2026-02-10
2025-09-30	$10,493,687	3,656,337	+315.0%	Shares	Sole	2025-11-10
2025-06-30	$2,123,125	880,965	+5.4%	Shares	Sole	2025-08-07
2025-03-31	$1,847,261	835,865	+186.9%	Shares	Sole	2025-05-08
2024-12-31	$1,587,933	291,364	+288.5%	Shares	Sole	2025-02-10
2024-09-30	$623,250	75,000	-62.5%	Shares	Sole	2024-11-07
2024-06-30	$1,432,000	200,000	+26.5%	Shares	Sole	2024-08-07
2024-03-31	$1,371,169	158,151	-49.2%	Shares	Sole	2024-05-09
2023-12-31	$2,038,425	311,210	—	Shares	Sole	2024-02-07
No filing history on record for this holder in this stock.